VANCOUVER, Washington, May 27, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing Vyrologix™ (leronlimab-PRO 140...
VANCOUVER, Washington, April 07, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5...
WESTLAKE VILLAGE, Calif. and BELO HORIZONTE, Brazil, June 03, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) and BIOMM SA (BVMF:BIOM3) today announced that Afrezza® (insulin human...
VALENCIA, Calif. and BELO HORIZONTE, Brazil, May 31, 2017 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) and BIOMM SA (BVMF:BIOM3) today announced that they have entered...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.02 | 12.0283018868 | 8.48 | 11.4 | 8.48 | 200580 | 10.03867584 | CS |
4 | 0.52 | 5.79064587973 | 8.98 | 11.4 | 7.79 | 135695 | 9.02136704 | CS |
12 | -4.32 | -31.2590448625 | 13.82 | 16.2 | 7.79 | 118623 | 11.55117501 | CS |
26 | 0.54 | 6.02678571429 | 8.96 | 21.2 | 7.79 | 155263 | 13.8236712 | CS |
52 | 4.27 | 81.6443594646 | 5.23 | 21.2 | 4.03 | 89756 | 13.10161724 | CS |
156 | -3.71 | -28.0847842544 | 13.21 | 21.2 | 3.1 | 40723 | 11.70454656 | CS |
260 | 1.4 | 17.2839506173 | 8.1 | 29 | 3.1 | 36968 | 13.04713649 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約